BeOne Medicines
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Free Cash Flow | 54,714 | -205,538 | -501,624 | -388,549 |
Cash | 2,701,933 | 2,592,655 | 2,793,370 | 3,171,800 |
Basic Shares | 1,380,494 | 1,375,532 | 1,358,374 | 1,354,719 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,458,779 | $1,415,921 | $1,176,283 | $308,874 |
Gross Profit | 2,078,859 | 1,129,446 | 1,011,377 | 238,217 |
Net Income | -881,708 | -2,003,815 | -1,457,816 | -1,624,974 |
Net Change In Cash | 2,458,779 | 1,415,921 | 1,176,283 | 308,874 |
Free Cash Flow | -1,753,714 | -1,965,718 | -1,613,574 | -1,510,469 |
Cash | 3,171,800 | 3,869,564 | 4,375,678 | 1,381,950 |
Basic Shares | 1,354,719 | 1,356,140 | 1,334,804 | 1,190,821 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.15 |
2024-06-30 | -$1.15 |
2024-03-31 | -$2.41 |
2023-12-31 | -$3.48 |
